Drug Transparency Bill Clears First Hurdle

A separate bill to require health insurers to be more transparent about costs and formularies for consumers did not pass. Drugmakers, who helped spur the opioid crisis, are now profiting off the epidemic by jacking up the price of overdose treatment Naloxone.

The House Health Committee cleared the drug manufacturer transparency bill on a 8-2 vote, with Republicans Rep. Knute Buehler of Bend and Rep. Rich Vial of Wilsonville joining the Democrats in the effort to force drug companies to explain the escalating rise in drug prices.

Source: Drug Transparency Bill Clears First Hurdle | The Lund Report